LEADER 02302nam 2200397 450 001 9910793663103321 005 20210406184425.0 010 $a1-4963-4942-3 035 $a(CKB)4100000008527076 035 $a(MiAaPQ)EBC6372335 035 $a(EXLCZ)994100000008527076 100 $a20210406d2020 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPeripheral vascular disease $ea clinical approach /$f[edited by] Carlos Mena, Sasanka Jayasuriya 210 1$aPhiladelphia, Pennsylvania :$cWolters Kluwer,$d[2020] 210 4$dİ2020 215 $a1 online resource (490 pages) $cillustrations 311 $a1-4963-4940-7 320 $aIncludes bibliographical references and index. 330 $a"Peripheral vascular disease refers to a cluster of conditions in which atherosclerosis (narrowing of the blood vessel wall) occurs in the peripheral vascular system, especially in the legs, causing significant disability and risk of amputation and infection. The worldwide prevalence of peripheral vascular disease, also known as peripheral arterial disease, increased 24% from 2000-2010, with about 70% of sufferers living in low to mid income regions. Approximately 202 million people suffered from peripheral vascular disease in 2010, with about 27 million in Europe and North America; 55 million in South East Asia; and 46 million in the Western Pacific region. Key risk factors include smoking, diabetes, hypertension, and high cholesterol. Given that peripheral vascular disease is more common in those over 60 years old, the incidence of disease is expected to grow as the population continues to age. Despite these statistics, many interventional cardiology fellowship programs do not include training on peripheral vascular interventions"--Provided by publisher. 606 $aPeripheral vascular diseases$xTreatment 615 0$aPeripheral vascular diseases$xTreatment. 676 $a616.131 702 $aMena$b Carlos$g(Carlos I. Mena-Hurtado), 702 $aJayasuriya$b Sasanka 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910793663103321 996 $aPeripheral vascular disease$93677556 997 $aUNINA